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Three-dimensional matrices that encapsulate and deliver stem cells with defect-tuned formulations are prom-
ising for bone tissue engineering. In this study, we designed a novel stem cell delivery system composed of
collagen and alginate as the core and shell, respectively. Mesenchymal stem cells (MSCs) were loaded into the
collagen solution and then deposited directly into a fibrous structure while simultaneously sheathing with
alginate using a newly designed core–shell nozzle. Alginate encapsulation was achieved by the crosslinking
within an adjusted calcium-containing solution that effectively preserved the continuous fibrous structure of the
inner cell-collagen part. The constructed hydrogel carriers showed a continuous fiber with a diameter of*700–
1000 mm for the core and 200–500 mm for the shell area, which was largely dependent on the alginate concen-
tration (2%–5%) as well as the injection rate (20–80mL/h). The water uptake capacity of the core–shell carriers
was as high as 98%, which could act as a pore channel to supply nutrients and oxygen to the cells. Degradation
of the scaffolds showed a weight loss of *22% at 7 days and *43% at 14 days, suggesting a possible role as a
degradable tissue-engineered construct. The MSCs encapsulated within the collagen core showed excellent
viability, exhibiting significant cellular proliferation up to 21 days with levels comparable to those observed in
the pure collagen gel matrix used as a control. A live/dead cell assay also confirmed similar percentages of live
cells within the core–shell carrier compared to those in the pure collagen gel, suggesting the carrier was cell
compatible and was effective for maintaining a cell population. Cells allowed to differentiate under osteogenic
conditions expressed high levels of bone-related genes, including osteocalcin, bone sialoprotein, and osteo-
pontin. Further, when the core–shell fibrous carriers were implanted in a rat calvarium defect, the bone healing
was significantly improved when the MSCs were encapsulated, and even more so after an osteogenic induction
of MSCs before implantation. Based on these results, the newly designed core–shell collagen-alginate fibrous
carrier is considered promising to enable the encapsulation of tissue cells and their delivery into damaged target
tissues, including bone with defect-tunability for bone tissue engineering.
Introduction
Tissue engineering has great promise as a strategy toenable regeneration of damaged or injured tissues, in-
cluding bone. As the key component, scaffolds play critical
roles in supporting cells in the initial adhesion, migration,
and proliferation. Among the cell sources, stem cells offer
great opportunities for regenerative therapy due to their self-
renewal and proliferative potential and the possible lineage
commitment under defined conditions.1,2 Whereas the de-
livery of stem cells to damaged tissues is considered prom-
ising, it has remained difficult to maintain a high survival
rate of cells under biological conditions associated with pH,
temperature, oxygen tension, and nutrient diffusion, thus
requiring a protected delivery. Further, stem cells need to be
given appropriate cues, such as signaling molecules, me-
chanical stiffness, or material composition to induce proper
cell differentiation and significant tissue regeneration
in vivo.3–5 A system that is both simple and reproducible,
which can be used either in the laboratory to pass to the
surgical room or directly during surgery, is also important.
Cell encapsulation has been shown to be an efficient
delivery system capable of protecting stem cells from the
surrounding tissues, while providing appropriate microenvi-
ronments for survival and differentiation. Hydrogel biopoly-
mers such as collagen, alginate, and chitosan have shown
cellular compatibility and the capacity to load and carry cells
to the target tissues.5–8 Collagen can load cells and has good
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biocompatibility, while maintaining cellular functions that mi-
mic the native three-dimensional (3D) tissue environment.9
Collagen also becomes a gel when pH, ionic concentration, and
temperature are modulated to near biological conditions.10
However, despite its excellent biocompatibility, it is very diffi-
cult to adjust the collagen hydrogels into various shapes for
tissue defect sites, while maintaining the hydrogel form.
As an alternative, alginate can be used to load tissue cells
within the structure and subsequently deliver them into the
defect site.11–13 When compared to other types of natural
polymer hydrogels such as collagen, alginate has a major ad-
vantage in that it does not disintegratewhen placed in aqueous
mediaandthereforemay retain the initial shapealsoallowingto
be formulated into different shapes, including microspheres
and fibers.14 This is because alginate possesses the useful
property of undergoing crosslinking when placed in contact
with divalent ions, such as calcium (Ca2+ ),15 thus allowing for
maintenance of the shape. Nevertheless, its biological proper-
ties are poor in terms of cell adhesion, migration, and viability,
and thus, it has usually been combined with other natural
polymers or specific sequences such as arginin-glycin-aspartic
acid (RGD) to enhance the cell survival rate.16
We aimed to develop a system that utilizes the best proper-
ties of alginate and collagen, and to develop a simple process
allowing the extrusionof large volumes of encapsulated cells. A
novel structured cell delivery systemwas developed based on a
hydrogel consistingof the collagen inner coreandalginateouter
shell, whereby cells are loaded and delivered in the collagen
inner part. Specifically, the core–shell hydrogel cell delivery
system was produced in a fibrous structure using a simple ro-
botic dispensingmachine, which we have previously used as a
dual drug delivery system.17 Deposition of fibers was made
through the concentric nozzle into an adjustedCa2+ -containing
bath. The crosslinking of alginate aided the structural stability,
while maintaining the shape of the collagen core. The proces-
sing tools used to generate the novel core–shell structured
collagen-alginate hydrogel carriers are described, and the via-
bility and proliferation of mesenchymal stem cells (MSCs)
within the hydrogel carriers aswell as their osteogenic potential
in vitro under defined biochemical cues were investigated. Fi-
nally, the ability to deliver MSCs in vivo and their new bone
formationwere addressed in a rat calvariummodel,whichmay
provide useful information on the use of the system in deliv-
ering stem cells for bone tissue engineering.
Materials and Methods
Core–shell fiber processing
A dual concentric nozzle (inner 23G and outer 17G) was
specifically designed and used to produce a core–shell
structured fibrous network of collagen-alginate. The sodium
alginate used (A2158; Sigma-Aldrich) had an M/G ratio of
1.67 and a molecular weight of *50,000 Da. Solutions of
sodium alginate at ratios of 2%–5% (% wt) in water were fed
into the outer syringe, while the collagen solution was loa-
ded in the inner syringe. The schematic representation is
shown in Figure 1a. The collagen (rat tail type I collagen;
First Link; 2.05mg/mL) solution was prepared by mixing
1mL of collagen with 100mL of 10· Dulbecco’s modified
Eagle medium and a proper amount of 1N sodium
hydroxide to provide a neutral pH to adjust solution con-
ditions for subsequent gelation and providing a nontoxic
environment for the loaded cells. Each syringe was attached
to an injection pump (KD Scientific) connected through a
microtube and the injection rate varied between 20 and
80mL/h. Core–shell structured collagen-alginate fibers were
then injected through the concentric nozzle into a bath con-
taining 50mM calcium chloride (CaCl2) for 5min. The whole
injection process was performed under sterile conditions.
Following injection, the outer alginate was in contact with
the calcium ions, which resulted in crosslinking and gelation
to maintain the stability of the fibrous cell carrier.
Characterizations of core–shell hydrogels
After deposition of the core–shell fibrous structure, the
thickness of the core and shell was measured from 10 arbi-
trarily selected images obtained by optical microscopy. Fi-
brous hydrogel samples prepared with varying injecting
speed (20, 50, and 80mL/h) or alginate concentration (2%,
3%, and 5%) were used for the measurement. The mechanical
properties of the fibrous hydrogels were measured by dy-
namic mechanical analysis (DMA; MetraVib, DMA25N) us-
ing a parallel plate configuration. For this, the deposited
fibers were stacked into a cylindrical Teflon mould (12mm
diameter · 6mm height) at a constant volume (0.5mL of
sample). Mechanical testing was carried out using dynamic
frequency sweep with frequencies ranging from 0.1 to 10Hz
at 37C and with strain amplitude of 5%, which was in the
linear region of viscoelasticity. Both auto-compression and
auto-strain adjustment were applied. The force was ramped
from 0.001 to 0.2N and the maximum allowed strain was set
at 10%. The storage modulus (E¢) and loss modulus (E†) of
the samples were measured. The phase angle delta (tan
delta) was computed as E†/E¢ (n = 3).
The water uptake capacity of the fibrous hydrogel cell
carriers was assessed. After immersion of each sample in
distilled water for 1 h, the sample was taken out and blotted
on a filter paper saturated with distilled water, and the
weight was recorded (Wim). After washing and freeze drying
the sample, the dried weight was recorded (Wdry). The water
uptake capacity was determined as (Wim -Wdry)/Wdry and
was expressed as percentage (n= 3). Degradation of the
samples (0.3mL for each sample) was tested by immersion
of each sample in phosphate-buffered saline (PBS) (n = 3).
After immersion for various time periods up to 21 days, the
sample was obtained, washed, and dried, and the weight
after the degradation test was recorded (Wdeg). The degra-
dation rate was considered as the percentage of (Wdry -
Wdeg)/Wdry.
Cell isolation
MSCs derived from rat bone marrow were harvested from
the femora and tibiae of adult rats (180–200 g) according to
the guidelines approved by the Animal Ethics Committee of
Dankook University. The harvested product was centrifuged
and the supernatant was collected and suspended within a
culture flask containing a normal culture medium; the a-
minimal essential medium (a-MEM) supplemented with 10%
fetal bovine serum (FBS) and 100U/mL penicillin and
100mg/mL streptomycin in a humidified atmosphere of 5%
CO2 in air at 37C. After incubation for 1 day, the medium
was refreshed and cultured until the cells reached near
confluence. The cells were subcultured by trypsin and
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maintained in the normal culture condition. Cells at two to
three passages were used for further tests.
Cell encapsulation
For cell encapsulation, sodium alginate powder was ster-
ilized with ethylene oxide and then preserved under sterile
conditions. The powder was mixed with distilled water to
produce 3% sodium alginate solutions. The collagen solu-
tions in product were in sterile conditions and were used as
received. To incorporate MSCs in the collagen hydrogel, the
collagen hydrogel was prepared as previously described,
incorporating 1 · 105 cells after the pH reached a neutral
value, which was observed by the color change of the col-
lagen solution (from yellow to orange-pink). The cell-loaded
collagen solution was put in the inner syringe, whereas the
alginate solution was in the outer syringe, and a fibrous
structuring was performed in sterile conditions as described
above. The amount of collagen present in the core–shell fiber
structure was maintained at 0.3mL for all cases (n = 3). As a
result, a cell-encapsulated fibrous hydrogel (cell-collagen in
the core and alginate in the shell) was obtained. After scaf-
fold construction for 5min, the cell-encapsulated hydrogel
was washed with a culture medium three times to remove
the excess CaCl2, and then cultured in the a-MEM containing
10% FBS and 1% penicillin/streptomycin in a humidified
incubator at 37C under 5% CO2 for up to 21 days. As the
positive control group, 0.3mL of collagen hydrogel con-
taining 1· 105 MSCs was molded in a culture well without
the core–shell fibrous structuring (n= 3).
Confirmation of cell viability and growth
The number of viable cells in the core–shell fibrous cell
carrier or in the collagen gel was measured. At each culture
period, hydrogel samples containing cells were washed
with PBS twice and dissolved with 1% type I collage-
nase (Sigma) for 5min at 37C. The suspension was then
centrifuged to remove the supernatant and the number of
viable cells was quantified by Trypan blue screening and
using a hemocytometer. The cell proliferative potential
was measured using the double-stranded DNA detection
kit (Quanti-iT Picogreen; Invitrogen). For this, the hydro-
gels incorporating cells were washed and dissolved with
1% type I collagenase (Sigma). After collecting the cell
pellet, the samples were stored at - 20C. The mixture was
then freeze–thawed by two repeating cycles. The cells were
quantified according to the manufacturer’s specifications
by measuring the fluorescence intensity at an excitation of
485 nm and emission of 530 nm. A standard curve was also
made according to the manufacturer’s instructions and
was used for converting fluorescence intensity to DNA
content.
Observation of cell morphology
The cell morphology was monitored under light micros-
copy using an Olympus BX-50 microscope during culture. At
each culture period (7, 14, and 21 days), the cells grown on
each sample were fixed with 4% paraformaldehyde and then
treated with 0.1% Triton X-100. After washing with PBS,
Alexa Fluor 546-conjugated phalloidin (Invitrogen A22283)
FIG. 1. Schematic showing the equipment setup for producing the stem cell-loaded collagen core and alginate shell hy-
drogel carrier. (a) Each solution of mesenchymal stem cell (MSC) collagen (2) and alginate (3) was advanced at a constant
speed from injectors (1), which were directly deposited using the core–shell needle (4, 5) designed for this study under a low
concentration (50mM) of calcium chloride solution bath (6), during which time the alginate was allowed to harden through
crosslinking of the Na-alginate with the Ca ion. The MSCs loaded within the collagen inner core became encapsulated within
the hardened alginate. The direct deposited cell construction was subsequently incubated at 37C to allow the gelation of
collagen, after which, it was further incubated for cell cultivation for bone tissue engineering. (b) Deposited core–shell
hydrogel carrier preserving a continuous fiber structure. (c) Core–shell fibrous hydrogel carrier is easily molded into any
determined shape (letter DKU replicated as an example), tuning to the tissue-defect geometry.
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diluted in PBS was added to each sample to stain the F-actin.
A ProLong Gold antifade reagent with 4¢,6-diamidino-2-
phenylindole (Invitrogen) was used to stain the cells and
produce blue fluorescence upon binding to the DNA in the
nucleus, after which, images were obtained by confocal laser
scanning microscopy using a Zeiss LSM 510 microscope.
Determination of cell differentiation by quantitative
polymerase chain reaction
MSCs encapsulated within the hydrogel cell carrier were
induced to osteogenic differentiation in an osteogenic me-
dium containing 50 mg/mL ascorbic acid, 10mM b-glycerol
phosphate, and 10 nM dexamethasone. Gene expression as-
sociated with osteogenesis, including osteocalcin (OCN),
bone sialoprotein (BSP), and osteopontin (OPN), was as-
sessed by quantitative polymerase chain reaction (qPCR).
After culture for 14 and 21 days, the cell-loaded scaffolds
were washed and then dissolved with collagenase. The cell
pellet was collected and frozen at - 80C until used. Total
RNA was extracted from differentiated cells using the
RNeasy Kit (Qiagen) according to the manufacturer’s in-
structions. The concentration of RNA samples was quanti-
fied using a Nanodrop 2000 spectrophotometer (Thermo
Scientific). RNA samples were transcribed into cDNA by
combining the RNA with random hexamer, followed by
denaturation at 70C for 5min. After denaturation, the
samples were mixed with the reverse transcription (RT)
premix for complete cDNA synthesis. cDNA was then am-
plified using RT-PCR premix (Bioneer) at 94C for 5min,
followed by 35 cycles of 94C for 1min denaturation, 57C
for 1min for annealing, and 72C during 1min for extension.
Primers used for amplification were OCN: AGGACCCTCT
CTCTGCTCAC (forward), AACGGTGGTGCCATAGATGC
(reverse); BSP: CTGCTTTAATCTTGCTCTG (forward), CCA
TCTCCATTTTCTTCC (reverse); OPN: TCCAGCTGACTTG
ACTCATGG (forward), CCGATGAATCTGATGAGTCCTT
(reverse); and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH): CCATGTTTGTGATGGGTGTG (forward), GGAT
GCAGGGATGATGTTCT (reverse). Results were normalized
with respect to GAPDH.
In vivo delivery in rat calvarium defect
Tissue compatibility and the bone forming ability of the
MSCsdeliveringhydrogel cell carrierswere assessedusing a rat
calvarium defect model. The protocol of the housing, care, and
experimental protocol was approved by the Dankook Uni-
versity Institutional Animal Care and Use Committee, Korea.
Nine 11-week-old, 350–400g healthy male Sprague-Dawley
ratswere used. During the surgical operation, the animalswere
anesthetized with intramuscular injections of 80mg/kg zoletil
and 10mg/kg xylazine in the right quadriceps muscle. All in-
struments were sterilized before the procedures and all the
surgical procedures on animals were carried out under general
anesthesiausingsterile techniques.Followingamidline incision
through the skin and the excision of the periosteumusing aNo.
10 blade with a Bard–Parker scalpel, the cranial bone was ex-
posed. A 5-mm diameter, full-thickness cylindrical defect was
created at the midportion of each parietal bone by means of a
trephineburr.Twodefectswere createdoneach animal, and the
defects were randomized into three groups. The defect was
filled with 0.1mL of test sample. Group 1 consisted of the cell
carrier only. Group 2 comprised the cell carrier encapsulating
nondifferentiated MSCs. Group 3 contained the cell carrier en-
capsulatingdifferentiatedMSCs (n=4). For group3, theMSCs in
the hydrogel construct were cultured under an osteogenic me-
dium for one week. After the implantation, the subcutaneous
area was sutured with 4-0 absorbable suture material, and the
skin was subsequently sutured with 4-0 non-absorbable mono-
filament suture material. After surgery, the rats were housed
individually in cages under conditions at 20C–24C and 30%–
70%relativehumidity andkept onanalternating12-h light/12-h
dark cycle with standard pellet food and water provided ad li-
bitum. Animals were monitored for signs of infection, inflam-
mation, and adverse effects by visual observation for one week.
Analyses of bone regeneration
At 6 weeks postoperatively, the animals were sacrificed
for harvesting of the samples and surrounding tissues. The
specimens were harvested from each animal at the time of
euthanasia and fixed in 10% of neutral buffered formalde-
hyde solution for at least 24–48 h. The samples were imaged
using a high-resolution microcomputed tomography (mCT)
system (Skyscan 1072; Skyscan) to evaluate tissue recovery
and bone regeneration. The harvested samples were scanned
and serial coronally oriented tomograms were reconstructed
from the raw images using NRecon CT Reconstruction
software. A cylindrical region of interest (ROI) was precisely
positioned over the center of each defect, encompassing all
new bone within the defect site. Coronally oriented mCT
images were then reformatted in an axial orientation. Re-
constructed images over the ROI using a CTAn (Skyscan)
and 3D images were created. The total volume of newly
formed bone within each ROI was measured by assigning a
threshold for the total bone content (including trabecular and
cortical bone). Bone surface area and surface density were
also recorded. Four samples for each group were measured
and the total volume of bone is reported (mm3).
After mCT scanning, specimens were decalcified with the
RapidCal solution and dehydrated in a graded series of in-
creasingethanol concentrations (70%–100%), and then trimmed
and embedded in paraffin. Tissue sections*5mm in thickness
were prepared perpendicular to the cranial bone and the sec-
tions were stained with hematoxylin–eosin (HE) andMasson’s
trichrome (MT) for histopathological examination to check
biocompatibility and bone formation. Light microscopy digital
images were obtained using Meta-Morph and analyzed with
computerized image analysis system (Molecular Devices).
Statistical analysis
Experiments were performed in triplicate, unless other-
wise specified. Data are expressed as mean– one standard
deviation. Statistical analysis was carried out by one-way
analysis of variance with the Fisher’s post hoc test and the
significance level was considered at p < 0.05 or p< 0.01.
Results
Generation of core–shell hydrogel cell carriers
and properties
Using the device (depicted in Fig. 1a), core–shell struc-
tured hydrogel cell carriers could be produced. The core–
shell fibrous injection through the co-concentric nozzle and
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the gathering of fibrous scaffolds were optically visualized
(Fig. 1b). A continuous fiber preserving the core–shell
structure, where the alginate encapsulated the collagen-MSC
inner part was successfully generated. The fibrous hydrogel
could be easily molded into any determined shape; a letter
DKU using a prefabricated mold is shown as an example
(Fig. 1c), indicating the tunability of the core–shell fibrous
device to tissue defect 3D geometry.
Controlling the thickness of the core and shell part was
possible by changing the alginate concentration and the in-
jection speed, which could significantly affect the nutrient/
oxygen penetration and the survival of cells encapsulated.
Figure 2 shows the effect of these parameters on the shell and
core thickness values. The shell thickness increased as the
alginate concentration increased (from 200 mm at 2% alginate
to 450mm at 5% alginate, shown in Fig. 2a). The core thick-
ness decreased at the highest alginate concentration (Fig. 2b).
The core–shell morphologies also reflected well the core and
shell thickness change with respect to the alginate concen-
tration (Fig. 2c–e). The effect of injection speed was also
clearly seen; the shell thickness increased as the injection
speed increased (from 100mm at 20mL/h to 400mm at
80mL/h; Fig. 2f), while the core thickness was not changed
(Fig. 2g). The optical images also represent the core–shell
thicknesses with varying the injection speed (Fig. 2h–j).
The mechanical properties of the core–shell hydrogel cell
carrier were measured by DMA. Samples prepared with
varying alginate concentrations were compared. Storage
modulus (E¢) and loss modulus (E") values recorded at dif-
ferent frequencies are shown in Figure 3. The storage mod-
ulus increased as the alginate concentration increased (from
30kPa at 2% alginate to 50 kPa at 5% alginate; Fig. 3a),
suggesting that an increasing alginate concentration im-
proved the ability to withstand plastic deformation. The loss
FIG. 2. Effect on alginate shell thickness of (a–e) alginate concentration and (f–j) injection speed. (a) Shell and (b) core
thickness measured with respect to varying alginate concentrations. Optical images showing the core–shell fiber morphol-
ogies produced with different alginate concentrations; (c) 2%, (d) 3%, and (e) 5%. (f) Shell and (g) core thickness measured
with respect to varying injection speed. Optical images showing the core–shell fiber morphologies produced with different
injection speed; (h) 20, (i) 50, and (j) 80mL/h. Arrows indicate the core thickness. Scale bars = 400mm. Color images available
online at www.liebertpub.com/tea
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modulus presented very similar values for the different al-
ginate concentrations (Fig. 3b), suggesting that the viscous
behavior of the scaffolds was not affected by the alginate
concentration. Whereas the storage modulus did not show
close dependence on the frequency parameter, the loss
modulus showed an almost linear increase as the frequency
increased. Moreover, the storage modulus values recorded
were higher than the loss modulus values for all cases.
Degradation of the core–shell hydrogel cell carrier was
measured in PBS over 21 days. The cell carrier obtained with
3% alginatewas tested as the representative group.Weight loss
measuredwas*4%after 3days,*22%after 7days, and*43%
after 14 days (Table 1). Further, the cell carrier was shown to
take up water as high as 98%, as taken from the weight change
between thehydrogel and freeze-dried samples, demonstrating
a typical characteristic of hydrogels.
MSC proliferation, morphology, and osteogenesis
The proliferative potential and viability of MSCs encap-
sulated in the core–shell hydrogel carrier were investigated.
FIG. 3. Mechanical properties of the core–shell structured fi-
brous hydrogel cell carriers produced with different alginate
concentrations (2%, 3%, and 5%), as measured by a dynamic
mechanical analysis; (a) storage modulus and (b) loss modulus
were recorded at varying frequency (from0.1 to 10Hz).Whereas
storagemodulus noticeably increased as alginate concentrations
increased, not much change was observed in the loss modulus.
Color images available online at www.liebertpub.com/tea
Table 1. Degradation of Core–Shell Fibrous Hydrogel
Cell Carrier in Phosphate-Buffered Saline
Period in phosphate-
buffered saline (days)
1 3 5 7 14
Degradation (%) 1.9 4.4 14.2 22.4 43.4
Samples produced with 3% alginate were tested as the represen-
tative group.
FIG. 4. (a) Proliferation of MSCs within the core–shell fi-
brous hydrogel carrier over 21 days, as assessed by the DNA
quantification. Results are compared with the MSCs cultured
within collagen hydrogel used as a positive control. Cell
proliferation comparable at 7 days became different at pro-
longed periods of 14 and 21 days (core–shell < collagen,
*p < 0.05, statistically different). (b) Live/dead cells quanti-
fied for both groups by trypan blue screening and hemocy-
tometer counting, showing comparable levels for both cases
(*70% survival rate at all time points). (c) Collagen core
shrinkage measured for up to 21 days, showing a consider-
able decrease in the core size from *1050mm (initial) to
900 mm at 7 days, 500 mm at 14 days, and 350 mm at 21 days.
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Results were compared with the MSCs cultured within the
collagen hydrogel matrix, which has been shown to be an
effective 3D matrix for cell growth and population and thus
used in this study as a positive control. From DNA analysis,
MSCs were shown to actively proliferate for both groups
with an on-going increase in the proliferation level over 21
days (Fig. 4a). Whereas the cell proliferation level was
comparable during 7 days for both groups, the proliferation
in the collagen became significantly higher than that in the
core–shell design after 14 and 21 days. Live/dead cell assays
revealed comparable levels for both the collagen and core–
shell groups, with *70% of cell viability at all culture peri-
ods (Fig. 4b). Figure 4c shows the shrinkage of the collagen
core where MSCs populated and proliferated over 21 days.
There was a considerable decrease in the core diameter from
1050mm (initial) to 900mm at 7 days, 500 mm at 14 days, and
350mm at 21 days.
Figure 5 displays representative optical microscopy images
of MSCs during culture for up to 21 days when encapsulated
within the core–shell fibrous hydrogel carrier as well as those
incorporated within collagen gel. MSCs initially displayed a
round shape soon after encapsulation (Fig. 5a) and a number
of cytoskeletal extensions were evident after 7 days of culture
(Fig. 5c), which was similarly observed in the collagen gel
control group (Fig. 5b, d). Cells in the core–shell carrier be-
came highly elongated at day 14 (Fig. 5e). Interestingly, the
cells showed directional elongation along the fiber axis. The
cells in the collagen were also highly elongated, but ran-
domly elongated (Fig. 5f). At 21 days, the cells in the core–
shell carrier reached near confluence within the collagen core
FIG. 5. Optical microscopic im-
ages of the core–shell hydrogel
carrier, encapsulating MSCs at dif-
ferent culture periods (a, c, e, g) and
collagen gel control incorporating
MSCs at the corresponding culture
period (b, d, f, h). MSCs with a
round shape initially at the time of
seeding (a, b), became spindle
shaped at 7 days (c, d), and then
highly elongated at 14 days (e, f).
At 21 days (g, h), cells proliferated
extensively to reach near conflu-
ence. Collagen core part in the core–
shell carrier appeared to shrink
substantially with increasing cul-
ture time. Scale bars= 350mm. Color
images available online at
www.liebertpub.com/tea
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(Fig. 5g), and a similar behavior was observed in the colla-
gen gel (Fig. 5h). The collagen core part in the core–shell
system appeared to shrink substantially at prolonged culture
periods.
The cellular cytoskeletal process and elongation mor-
phology were revealed after immunofluorescence staining
of the cells and observation under confocal microscopy, as
shown in Figure 6. MSCs with limited cytoskeletal exten-
sions at day 7 (Fig. 6a, b) showed pronounced elongation,
forming a highly networked structure among the cells at
day 14 (Fig. 6c, d). The cell networks appeared to be formed
primarily at the outer surface of the core part, that is, close
to the core–shell boundary. Once cell confluence at the
surface region was reached, cells grew and proliferated at
the inner region of the collagen core part, and at day 21,
cells formed more dense networks throughout the colla-
gen core, which was highly oriented along the fiber axis
(Fig. 6e, f).
The osteogenic differentiation of the MSCs cultured in the
core–shell fibrous carrier was assessed in terms of expression
of genes related with bone, including BSP, OPN, and OCN.
Figure 7 shows the mRNA expression levels of those genes
(expression levels presented by normalizing to collagen gel
at 14 days) by qPCR analysis. After culture for 14 days, all
genes were expressed at levels significantly higher in the
core–shell carrier than in the collagen gel; fold increases were
1.6, 3.0, and 5.5, respectively, for BSP, OPN, and OCN. At 21
days, however, the difference was reduced.
In vivo bone forming ability of the MSC delivery system
The tissue compatibility and bone forming ability of the
MSC-encapsulated core–shell hydrogel carrier was further
assessed using a rat calvarium model. Three different groups
were studied: core–shell carrier only, carrier with MSCs as
encapsulated, and carrier with MSC encapsulation followed
by osteogenic differentiation for 7 days. Throughout the 6-
week study period, animals showed a good healing response
without adverse tissue reactions and material toxicity, as
well as there were no visible signs of internal inflammation
on the harvested tissues. Bone regeneration was examined
with mCT, as shown in Figure 8. The mCT constructed images
revealed new bone formation (orange colored) within the
defect region for the three groups (Fig. 8a). Different levels of
bone regeneration from the defect margins were noted.
Based on the mCT images, the percent bone volume, bone
surface area, and bone surface density were quantified.
Whereas the percent bone volume of the carrier only was
*13%, that of MSC-encapsulated carrier showed 25%, and
the differentiated MSCs increased the bone volume as high
as 45% (Fig. 8b). The bone surface area and bone surface
density also showed the effectiveness of the carrier encap-
sulating MSCs with osteogenic differentiation (Fig. 8c, d).
New bone formation and defect closure were revealed
again by histological views after HE and MT stains, as
shown in Figure 9. All three groups showed good biocom-
patibility with no significant notice of inflammatory cells. HE
FIG. 6. Confocal laser scanning
microscopy showing the cellular
cytoskeletal processes and the
elongation morphology within the
core–shell fibrous carrier after 7 (a,
b), 14 (c, d), and 21 days (e, f). Cell
nucleus stained in blue (4¢,6-diami-
dino-2-phenylindole) and the cyto-
skeleton in red (Alexa Fluor
Phalloidin 548). Scale bars = 850mm
(a, c, and e) and 350mm (b, d,
and f). Color images available
online at www.liebertpub.com/tea
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stains revealed cell and/or tissue in-growth within the defect
region. MT stains showed more clearly the newly formed
bone within the defect area. The carrier only group showed
primarily loose connective tissue formed within the defect
with a limited amount of new bone formation at the margin
(Fig. 9a). In contrast, when undifferentiated MSCs were en-
capsulated within the carrier, a level of new bone formation
(indicated as NB) was revealed at the center of defect (Fig.
9b). The group using carrier with differentiated MSCs
showed a significant level of newly formed bone at the
central regions of the defect (Fig. 9c). At higher magnification
of the newly formed bone in Figure 9c, the new bone was
proven to be mature with a compact structure and lined with
many osteoblasts (Fig. 9d).
Discussion
Delivery of cells to tissue defect sites requires the use of
appropriate 3D matrices that support the cell growth and are
FIG. 7. Osteogenic differentiation of the MSCs cultured in
the core–shell fibrous hydrogel carrier over 14 and 21 days.
mRNA levels of bone sialoprotein (BSP) (a), osteopontin
(OPN) (b), and osteocalcin (OCN) (c) genes were quantita-
tively assessed. * Indicates significant differences ( p< 0.05, by
analysis of variance).
FIG. 8. In vivo bone forming ability of the MSC-encapsu-
lated core–shell hydrogel carrier. Three sample groups tested
include carrier only (w/o cells), carrier with undifferentiated
MSCs (nonosteogenic), and carrier with differentiated MSCs
for 7 days in an osteogenic medium (osteogenic). Bone re-
generation was analyzed by microcomputed tomography
(mCT) after 6 weeks of implantation: (a) mCT constructed im-
ages showing the new bone formation (orange color) around
the 5-mm-diameter defect region. Quantitative results show-
ing (b) percent of new bone volume, (c) bone surface area, and
(d) bone surface density. Significant differences were noticed
(*p< 0.05 and **p< 0.01, by analysis of variance). Color images
available online at www.liebertpub.com/tea
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biologically compatible and even tunable to the defect shape.
The cells loaded in the 3D matrices can be directly delivered
to target defects, or cultured ex vivo to form a tissue-en-
gineered construct that better mimics the native tissue
structure and composition. Many types of 3D matrices have
been developed to engineer and deliver cells to regenerate
various tissues, including skin, bone, cartilage, nerve, and
blood vessels.
In this study, a core–shell structured hydrogel system was
designed as the 3D matrix for cell delivery. The hydrogel cell
carrier was made of two clearly distinguished zones, an in-
ner cell encapsulating collagen part ensheathed with an outer
alginate. Specifically, the core–shell structure was generated
into a fibrous morphology with diameters of hundreds of
micrometers by directly depositing the solutions through a
specially designed core–shell nozzle within a Ca-containing
culture medium bath (Fig. 1). When the sodium (Na)-
alginate meets the Ca ions, an ion exchange between Na and
Ca occurs, resulting in the formation of divalent Ca cross-
links to the alginate and development of a hardened network
of Ca-alginate outer shell.18 Due to the rapid crosslinking of
alginate, the cell-loaded collagen inner core could be main-
tained without loss of physical integrity. Because of these
traits of the core–shell structured collagen-alginate hydrogel
matrix, the water permeation and degradation properties are
largely dependent on the outer alginate composition, par-
ticularly the hydrogel density.18–20 Therefore, the core–shell
fibers had to be carefully designed by selecting the appro-
priate speed of injection as well as the optimal alginate
concentration to allow nutrient and oxygen diffusion to the
cells in the core. It has been previously reported that, for
hydrogels to allow cell survival, distances higher than 200–
250 mm in the system may reduce oxygen transport as well as
nutrient diffusion.21 Thus, the core–shell system had to be
designed for the shell thickness to lie within this range. It
was observed that a high injection speed (80mL/h) pro-
duced a thick shell inappropriate for encapsulating cells,
while a low speed (20mL/h) resulted in very slow scaffold
processing with an increased risk of cell death during the in
situ scaffold preparation (Fig. 2). Further, a high alginate
concentration (5%) created a thicker and denser shell layer,
possibly reducing the nutrient penetration, whereas a low
concentration (2%) produced a similar layer to that of
3%, but with faster degradation and poorer mechanical
FIG. 9. Representative histological images of implanted samples after hematoxylin and eosin (HE) and Masson’s trichrome
(MT) staining after 6 weeks of implantation; (a) carrier only, (b) with undifferentiated MSCs, (c) with differentiated MSCs,
and (d) enlarged image of newly formed bone in (c). (Arrows: defect margins, NB: new bone, HB: host bone). Scale
bar = 1mm (a–c) and 200 mm (d). Color images available online at www.liebertpub.com/tea
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properties (Fig. 2). Therefore, an intermediate speed (50mL/
h) with an intermediate alginate concentration (3%) was se-
lected for further cell encapsulation experiments.
To prove the ability of cells to survive in the designed
scaffold, MSCs were encapsulated in the collagen and en-
sheathed with 3% alginate, and the cell proliferation and
viability level were assessed in direct comparison with those
loaded within pure collagen gel. MSCs exhibited high levels
of viability, maintaining a proliferative potential comparable
to the pure collagen hydrogel matrix (Fig. 4). Based on the
optical cell images, as well as measurement of cell viability,
including the live/dead cell count, the engineered core–shell
collagen-alginate hydrogel delivery system provides ap-
propriate 3D matrix conditions for cells to undergo a series
of normal and favorable responses. Of particular note is the
fact that the cells in the core–shell fibrous hydrogel ex-
hibited preferential direction of growth along the fiber axis,
whereas in the collagen gel, the orientation was random.
Further, the cells were preferentially positioned in close
proximity to the alginate, forming hollow cylindrical cellu-
lar networks (Figs. 5 and 6). It is thought that the encap-
sulated cells favor and thus migrate to the areas where the
oxygen and nutrient levels are higher. Another finding is
the shrinkage of the collagen inner core toward the central
axis during the culture period, which is closely related with
the high proliferation of cells. It is thus considered that the
degradation of the core–shell hydrogel over culture period
was primarily from the collagen degradation. Although the
collagen inner core degraded to shrink a lot, cells prolifer-
ated substantially, forming a network along the fiber di-
rection, and the whole core–shell fibrous morphology could
be preserved due to the presence of a relatively stable al-
ginate shell. This suggests that the designed core–shell fi-
brous system is sufficient for the cell delivering tissue
engineering matrix, by encapsulating cells in an isolated,
but nutrient and oxygen permissible environment and de-
livering them to target defects.
After addressing the cell viability and morphological
traits, we further analyzed the osteogenic phenotype ex-
pression of the MSCs cultured within the core–shell delivery
system (Fig. 7). A series of osteogenic genes (OPN, BSP, and
OCN) were highly expressed at day 14, with levels signifi-
cantly higher than those in pure collagen gel. Although the
cell growth matrices are the same (collagen gel), the osteo-
genic development was differently processed. Some possible
explanations can be given. First, the different morphological
feature of cells (directional elongation vs. random spreading)
will influence the MSC osteogenic differentiation. Similar
effects have been previously found when cells were cultured
on aligned polymer fibrous matrices.22,23 Second, the con-
fined core–shell matrix would provide different microenvi-
ronments for MSCs to undergo cellular processes,
particularly osteogenic differentiation; the possible differ-
ences in cell-to-cell contact, secretion of endogenous signals,
nutrient diffusion, and oxygen levels might be the cause.24,25
However, further in-depth study is needed to elucidate
which parameter is the most significant, and thus to optimize
the MSC-loaded core microenvironments. It is further en-
visaged that the incorporation of signaling or osteogenic
factors within the core or shell part is a promising strategy
for exogenous regulation of stem cell functions.26 Composi-
tional change of the core material is another strategy to im-
prove the matrix properties for osteogenesis within the
current design of the core–shell delivery system.
When the osteogenic development of MSCs was con-
firmed under in vitro culture, we next sought to find the
efficacy of the MSC-delivering core–shell hydrogel system in
the in vivo bone regeneration. Three experimental groups
were tested in a rat calvarium defect for 6 weeks, which
includes core–shell carrier only, carrier with MSCs undif-
ferentiated, and carrier with MSCs differentiated for 7 days.
In fact, the delivery system was very effective for handling
and implantation, being easily formulated into the defects
made in calvarium, which allows possible uses in more
complex-shaped defect models. A first in vivo sign proved
that the cell carrier system had good biocompatibility with
no adverse tissue reaction or significant inflammation.
Whereas the core–shell carrier group exhibited only a limited
bone formation at the circumferential defect areas, the MSC-
delivering groups showed bone regeneration at the central
areas (Figs. 8 and 9). Moreover, when the MSCs delivered
were differentiated into an osteogenic lineage, the bone
ingrowth was more substantial. These results demonstrated
the role of MSCs, particularly those engineered into an os-
teogenic lineage, in the in vivo bone regeneration, and the
efficacy of the core–shell fibrous cell delivery system. The
MSCs in the core–shell carrier secrete signaling molecules to
the surrounding tissue allowing new bone formation, while
preserving cellular integrity within the hydrogel carrier
system. Based on this observation, the newly designed core–
shell fibrous hydrogel is believed to have potential future
applications as a stem cell delivering matrix and defect-
tuned bone tissue engineering.
Conclusions
A collagen core-alginate shell fibrous hydrogel scaffold
was designed for the delivery of cells and for tissue engi-
neering of bone. The hydrogel scaffold was shown to provide
3D matrix conditions appropriate for MSCs to survive and
proliferate, and to undergo osteogenic differentiation using
appropriate chemical cues. Further, the MSCs delivered
through hydrogel scaffolds showed great potential for
regenerating bone tissue in a rat calvarium model. Taken
together, the newly developed core–shell structured colla-
gen-alginate system may be useful for tissue engineering and
the delivery of stem cells in regeneration of damaged and
degenerated bone tissues.
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